A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procep) became aware that post-aquablation procedure, the patient was taken back to the operating room (or) for additional cauterization.Post aquablation procedure, and during resection to achieve hemostasis, the catheter was reserved to be red, at which point a company representative discussed with the surgeon the ideal effluent color and focal bladder neck cautery technique to achieve proper hemostasis; however, the surgeon decided to end the procedure after approximately 40 minutes of resection.Post aquablation procedure the patient became hypotensive, was administered two (2) units of blood and was taken back to the operating room to address the bleeding with additional cauterization.The patient was reported to be in good condition.No malfunction of the aquabeam robotic system was reported during this event.Per the manufacturer's instructions for use, prostate bleeding is a perioperative risk of the aquablation procedure.
|
H.10 additional manufacturer narrative: the aquabeam robotic system was not returned for investigation of this event and is currently in use at the user facility.The investigation consisted of a review of the information reported to procept, plus a review of the event log files, device history record (dhr), and labeling.A review of the device history record (dhr) ab2000-b/serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: o bleeding a root cause for the reported event could not be determined.The aquabeam robotic system's ifu lists bleeding as a potential risk of the aquablation procedure.Based on the information obtained through the treating surgeon and a review of the treatment log files, dhr, and ifu the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|